Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.

Triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer, lacking targeted therapies due to its molecular characteristics. Tumor-associated ...

INAB READ THE FULL INAB RESEARCH REPORT IN8bio, Inc (NASDAQ:INAB) updates survival data for its INB-100 trial in a February ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Predicting how cancer patients will respond to treatment remains a critical challenge. Immune checkpoint inhibitors (ICIs), a ...

Neutrophils can be overactive in several ... which is also reported to have many pharmacological and health characteristics like being anti-inflammatory, anti-ulcer, anti-prostaglandin, anti ...

and low density neutrophils based on functional characteristics. - Neutrophils in certain autoimmune diseases may also be classified into different subsets, with low density granulocytes (LDGs) ...